Frontiers in Cardiovascular Medicine最新文献

筛选
英文 中文
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillation.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1433790
Eva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, Robin Wesselink, Rushd F M Al-Shama, Wim-Jan P van Boven, Antoine H G Driessen, Wouter R Berger, Jonas S S G de Jong, Joris R de Groot
{"title":"Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillation.","authors":"Eva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, Robin Wesselink, Rushd F M Al-Shama, Wim-Jan P van Boven, Antoine H G Driessen, Wouter R Berger, Jonas S S G de Jong, Joris R de Groot","doi":"10.3389/fcvm.2025.1433790","DOIUrl":"10.3389/fcvm.2025.1433790","url":null,"abstract":"<p><strong>Background: </strong>Obesity is an important risk factor for atrial fibrillation (AF) development and progression. Furthermore, obesity reduces health-related quality of life (HRQoL), an essential indicator for treatment efficacy of AF ablation. Nevertheless, the extent to which obesity influences changes in HRQoL and the recurrence of AF following ablation, especially thoracoscopic AF ablation, remains largely unexplored.</p><p><strong>Aims: </strong>We assessed in obese vs. non-obese patients undergoing thoracoscopic AF ablation: (1) HRQoL upon ablation, (2) AF recurrence incidence, (3) the association between recurrence incidence and HRQoL.</p><p><strong>Methods & results: </strong>408 prospectively enrolled patients were included for analysis. Heart rhythm was systematically monitored during follow-up. AF recurrence was defined as any atrial tachyarrhythmia episode > 30 s. HRQoL and recurrence incidence were assessed for normal weight (BMI ≤ 24.9 kg/m<sup>2</sup>), overweight (25.0-29.9 kg/m<sup>2</sup>) and obese (≥30.0 kg/m<sup>2</sup>) patients. HRQoL was assessed at baseline and 1-year follow-up. Obese patients scored lower in pre-operative HRQoL across 6/8 subscales vs. non-obese patients (<i>p</i> < 0.01-0.05). While HRQoL increased in all patients, obese patients showed a trend towards an even greater improvement of mental HRQoL (<i>p</i> = 0.07) vs. non- obese patients. In obesity, mental HRQoL increased similarly for those with and without AF recurrence (<i>p</i> = 0.78), whereas in non-obese patients, AF recurrence was associated with less improved mental HRQoL (<i>p</i> = 0.03). AF recurrence at 1-year was similar between all weight groups (72.4%, 68.0%, 70.4%, <i>p</i> = 0.69).</p><p><strong>Conclusions: </strong>After thoracoscopic ablation, obese patients experience a comparable incidence of AF recurrence as non-obese patients. Interestingly, obese patients also exhibit a more significant enhancement in mental quality of life, regardless of whether AF recurs or not.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1433790"},"PeriodicalIF":2.8,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11914143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143656633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metagenomic next-generation sequencing identifies native valve Aspergillus fumigatus endocarditis with cerebral involvement: a case report. 元基因组下一代测序发现原生瓣膜曲霉菌心内膜炎并累及大脑:一份病例报告。
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1487543
Weibing Wu, Jingjing Xu, Jianling Ruan, Baoping Tian, Nanxia Xuan
{"title":"Metagenomic next-generation sequencing identifies native valve Aspergillus fumigatus endocarditis with cerebral involvement: a case report.","authors":"Weibing Wu, Jingjing Xu, Jianling Ruan, Baoping Tian, Nanxia Xuan","doi":"10.3389/fcvm.2025.1487543","DOIUrl":"10.3389/fcvm.2025.1487543","url":null,"abstract":"<p><p>Aspergillus endocarditis is a rare but highly fatal condition, particularly in immunocompromised patients. This case report describes a 74-year-old male with native valve Aspergillus fumigatus endocarditis and intracranial infection. Diagnosis was complicated by atypical presentation and negative blood cultures, but metagenomic next-generation sequencing (mNGS) enabled rapid identification of the pathogen. This case is notable for being the first to document Aspergillus fumigatus endocarditis with cerebral involvement confirmed by mNGS, highlighting the importance of early diagnosis and advanced diagnostic tools in improving outcomes.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1487543"},"PeriodicalIF":2.8,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11914112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143656629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of the Renal-guard system in the prevention of contrast-induced nephropathy following cardiac interventions among patients with chronic kidney disease.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1438076
Farah Yasmin, Yusra Mashkoor, Hala Najeeb, Ayra Asim Shaikh, Butool Nusrat, Abdul Moeed, Muhammad Sohaib Asghar, Chadi Alraies
{"title":"Efficacy of the Renal-guard system in the prevention of contrast-induced nephropathy following cardiac interventions among patients with chronic kidney disease.","authors":"Farah Yasmin, Yusra Mashkoor, Hala Najeeb, Ayra Asim Shaikh, Butool Nusrat, Abdul Moeed, Muhammad Sohaib Asghar, Chadi Alraies","doi":"10.3389/fcvm.2025.1438076","DOIUrl":"10.3389/fcvm.2025.1438076","url":null,"abstract":"<p><strong>Background: </strong>Contrast-induced nephropathy (CIN), also called as contrast associated-acute kidney injury (CA-AKI) is a common complication following cardiac procedures. KDIGO guidelines define CIN as a ≥25% increase in serum creatinine or an absolute increase of at least 0.5 mg/dl 48-72 h post-contrast administration. The single most effective measure in preventing CIN is peri-procedural intravascular hydration typically from 12 h before to 24 h after contrast media exposure but has limitations. Recently, the RenalGuard (RG) system has emerged as a new tool, demonstrating safer and more efficient hydration and reducing the incidence of AKI caused by CIN.</p><p><strong>Aims: </strong>We conducted this meta-analysis on the effectiveness of the RG system in preventing CIN in patients undergoing cardiac interventions.</p><p><strong>Methods: </strong>A comprehensive literature search of PubMed (MEDLINE), Science Direct, and Embase was conducted from its inception until February 2024 for randomized controlled trials (RCTs) including patients aged >18 years undergoing cardiac procedures with underlying chronic kidney disease (CKD), estimated glomerular filtration rate (eGFR) 20-60 ml/min/1.73 m<sup>2</sup> and left ventricular ejection fraction (LVEF) >50%. The outcomes of interest were risk of CIN, risk of renal replacement therapy (RRT), in-hospital mortality and 30-day mortality, major adverse cardiovascular events (MACE), changes in serum creatinine (sCr) levels, and incidence of pulmonary edema. A random-effects meta-analysis was performed using Review Manager (RevMan) [Computer Program] Version 5.4 Cochrane Collaboration.</p><p><strong>Results: </strong>A total of 9 RCTs including 3,215 patients with CKD undergoing cardiac procedures on volume expansion strategies were included with 1,802 patients on the RG system and 1,413 patients using alternate volume expansion techniques. Pooled analysis of 9 RCTs reported a significantly lower risk of CIN in patients using the RG system vs. control [OR 0.51 (0.35, 0.74), <i>P</i> = 0.0004; I<sup>2</sup> = 55%]. There was no significant difference in the risks of RRT, in-hospital mortality, 30-day MACE, pulmonary edema, or change in sCr levels.</p><p><strong>Conclusion: </strong>This meta-analysis indicates the beneficial utilization of the RG system in populations with moderate-to-high risk and underlying CKD undergoing cardiac interventions in preventing CIN. However, it did not demonstrate a notable impact on mortality, RRT, MACE, pulmonary edema, and sCr levels when compared to the control group.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1438076"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crosstalk between lipid metabolism and macrophages in atherosclerosis: therapeutic potential of natural products.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1529924
Taoming Qian, Donghao Guo, Lu Sun, Ming Chi, Xiaoshuang Ma, Juan Jin
{"title":"Crosstalk between lipid metabolism and macrophages in atherosclerosis: therapeutic potential of natural products.","authors":"Taoming Qian, Donghao Guo, Lu Sun, Ming Chi, Xiaoshuang Ma, Juan Jin","doi":"10.3389/fcvm.2025.1529924","DOIUrl":"10.3389/fcvm.2025.1529924","url":null,"abstract":"<p><p>Atherosclerosis is a highly prevalent cardiovascular condition that affects individuals worldwide. Despite ongoing research into its treatment and prevention, atherosclerotic cardiovascular disease continues to exhibit high morbidity and mortality rates. The accumulation of low-density lipoprotein cholesterol is considered a major contributor to the development of atherosclerosis, with abnormalities in lipid metabolism playing a significant role in its pathogenesis. Lipid metabolism and macrophage function are intricately interconnected, with lipid metabolism being influenced by macrophage inflammatory responses, while macrophage activity is regulated by alterations in lipid metabolism. The interaction between these two processes plays a critical role in the progression of atherosclerosis. Natural products have shown considerable promise in treating a variety of diseases, including atherosclerosis. Moreover, the modulation of lipid metabolism and macrophage crosstalk represents a key mechanism through which natural products may exert their effects. This research aims to provide new insights into the current state of research on the role of natural products in regulating this pathway and the interplay between lipid metabolism and macrophages in the context of atherosclerosis, offering potential directions for the future.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1529924"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients: a comprehensive analysis using speckle tracking echocardiography.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1548119
Ning Zhang, Na Wang, Yanyan Zhang, Ya Liu, Miaomiao Pei, Gaiqin Liu, Xinle Jia, Xuejia Guo
{"title":"Corrigendum: Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients: a comprehensive analysis using speckle tracking echocardiography.","authors":"Ning Zhang, Na Wang, Yanyan Zhang, Ya Liu, Miaomiao Pei, Gaiqin Liu, Xinle Jia, Xuejia Guo","doi":"10.3389/fcvm.2025.1548119","DOIUrl":"10.3389/fcvm.2025.1548119","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fcvm.2024.1413827.].</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1548119"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimizing stroke risk in off-pump CABG: the role of clampless devices and the piggyback proximal anastomosis technique.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1555394
Massimo Baudo, Francesco Cabrucci, Amanda Yakobitis, Courtney Murray, Gianluca Torregrossa
{"title":"Minimizing stroke risk in off-pump CABG: the role of clampless devices and the piggyback proximal anastomosis technique.","authors":"Massimo Baudo, Francesco Cabrucci, Amanda Yakobitis, Courtney Murray, Gianluca Torregrossa","doi":"10.3389/fcvm.2025.1555394","DOIUrl":"10.3389/fcvm.2025.1555394","url":null,"abstract":"<p><strong>Introduction: </strong>Numerous techniques have been developed to minimize risk of perioperative stroke during coronary artery bypass grafting (CABG), including off-pump approach, preoperative and intraoperative imaging of the ascending aorta (CT scan and epiaortic ultrasound), anaortic CABG with bilateral internal thoracic artery, clampless devices for the construction of proximal anastomosis and minimal aortic manipulation with a single aortic inflow for all proximal grafts (piggyback proximal anastomosis). The aim of this study was to evaluate the clinical outcomes of CABG patients who underwent off pump CABG with proximal anastomosis constructed with the use of a clampless device and in a piggyback fashion.</p><p><strong>Methods: </strong>This observational study included 112 consecutive patients undergoing CABG with the piggyback proximal technique at the Lankenau Heart Institute between June 2021 and January 2024. Primary endpoints included overall mortality, cardiac-related mortality, stroke, myocardial infarction, repeat revascularization. Intraoperative transit time flow measurement (TTFM) was also analyzed.</p><p><strong>Results: </strong>The mean age of the cohort was 67.8 ± 8.7 years, with 75.9% (85/112) being male. All patients underwent off-pump CABG. The piggyback anastomosis consisted of vein-on-vein (52.7%, 59/112), artery-on-vein (43.8%, 49/112), and double vein/artery configurations (3.6%, 4/112). Postoperatively, no strokes occurred. At 30 days no patient died or required repeat revascularization. The mean hospital stay was 5.5 [4.0-8.0] days. At a mean follow-up of 1.0 [0.5-1.7] years, no cardiac deaths were recorded, with an overall survival of 98.2% (110/112). Repeat piggyback revascularization was 3.6% (4/112) at a mean of 2.0 ± 0.5 years. TTFM demonstrated superior flow rates in artery-on-vein grafts [50 (40-70) ml/min] compared to vein-on-vein grafts [40 (30-53.5), <i>p</i> < 0.001].</p><p><strong>Conclusions: </strong>When a proximal anastomosis cannot be avoided during off pump CABG, the combination of a piggyback proximal anastomosis together with the use of a clampless aortic device, demonstrated promising early mid-term outcomes almost nullifying the perioperative risk of clinical stroke. Intraoperative TTFM showed excellent flow rates, especially when arterial grafts were used. The technique is a viable option in high-risk patients with severe aortic disease, offering a safe and effective approach to multivessel revascularization with minimal aortic manipulation. Further studies with longer follow-up are warranted to confirm its long-term benefits.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1555394"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlations of serum uric acid, fibrinogen and homocysteine levels with carotid atherosclerosis in hypertensive patients.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1433107
Liling Zhang, Shenlu Lu, Juanjuan Guo
{"title":"Correlations of serum uric acid, fibrinogen and homocysteine levels with carotid atherosclerosis in hypertensive patients.","authors":"Liling Zhang, Shenlu Lu, Juanjuan Guo","doi":"10.3389/fcvm.2025.1433107","DOIUrl":"10.3389/fcvm.2025.1433107","url":null,"abstract":"<p><strong>Objective: </strong>Uric acid (UA), fibrinogen (FIB), and homocysteine (Hcy) are the main contributors to cardiovascular and cerebrovascular diseases, and are related to hypertension. Hypertension plays a role in atherosclerosis (CAS). We hence explored the correlations of UA, FIB, and Hcy levels with CAS in hypertensive patients.</p><p><strong>Methods: </strong>Totally 170 hypertensive patients were retrospectively included and assigned into the Non-sclerosis, Thickened, and Plaque groups based on carotid intima-media thickness (cIMT), with serum UA, FIB, and Hcy compared. Correlations of UA, FIB, and Hcy with cIMT and carotid atherosclerotic plaque (CAP) were assessed using Spearman's correlation analysis. The risk factors of CAS were evaluated by logistic multivariate regression analysis. The predictive value of UA, FIB, and Hcy for CAS was estimated by the receiver operating characteristic (ROC) curve.</p><p><strong>Results: </strong>UA, FIB, and Hcy were up-regulated in the Plaque group vs. other two groups. Serum UA, FIB, and Hcy were positively linked to cIMT and CAP, and were independent risk factors for CAS. The area under ROC curve of UA, FIB, Hcy levels and their combination for predicting CAS were 0.889, 0.855, 0.902, and 0.958, respectively. Hypertensive patients with high levels of UA, FIB, or Hcy were more likely to develop CAS.</p><p><strong>Conclusion: </strong>Serum UA, FIB, and Hcy are positively correlated with cIMT and CAP, and are independent risk factors for CAS in hypertensive patients. High UA, FIB and Hcy expression could assist in predicting CAS in patients with hypertension, and the combination of the three was more valuable than all three alone.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1433107"},"PeriodicalIF":2.8,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: "Dumbbell" giant right coronary artery ectasia with right atrial fistula.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1498359
Jianggui Shan, Heng Wang, Song Xue
{"title":"Case Report: \"Dumbbell\" giant right coronary artery ectasia with right atrial fistula.","authors":"Jianggui Shan, Heng Wang, Song Xue","doi":"10.3389/fcvm.2025.1498359","DOIUrl":"https://doi.org/10.3389/fcvm.2025.1498359","url":null,"abstract":"<p><p>A 50-year-old female patient presented with a \"dumbbell\" giant right coronary artery ectasia, characterized by two artery dilation segments both reaching the level of a giant aneurysm with a normal segment between them. Computed tomography angiography showed a fistula sac in the right atrium. The vessel shape was a typical type IV (localized or segmental) coronary artery ectasia, which is rarely seen on true imaging. The patient had a 3-year history of chest tightness, without dyspnea, worsened by physical activity. Additional tests indicated that she had mitral valve regurgitation, superficial myocardial bridge, and anemia, all of which led to the development of her symptoms. She felt relieved after successful coronary artery fistula repair, mitral valvuloplasty, and fistula sac removal. At the 6-month follow-up, no complications were found according to echocardiography. Patients with coronary aneurysms can be asymptomatic in the early stage, while this case indicates that the dumbbell shape may be a developing stage of giant coronary aneurysm whose origin and close-fistula segments are influenced by separate hydrodynamics during ectasia or aneurysm formation.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1498359"},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11906408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perclose ProGlide closure devices vs. surgical removal for veno-arterial extracorporeal membrane oxygenation decannulation: a meta-analysis.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1482305
Qian Zhang, Ke Guo, Yunping Liu, Wei Wei, Kan Zhao, Haijun Huang, Zuoyi Yao
{"title":"Perclose ProGlide closure devices vs. surgical removal for veno-arterial extracorporeal membrane oxygenation decannulation: a meta-analysis.","authors":"Qian Zhang, Ke Guo, Yunping Liu, Wei Wei, Kan Zhao, Haijun Huang, Zuoyi Yao","doi":"10.3389/fcvm.2025.1482305","DOIUrl":"https://doi.org/10.3389/fcvm.2025.1482305","url":null,"abstract":"<p><strong>Objective: </strong>Perclose ProGlide closure devices (PPCDs) have become a more commonly used strategy in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) decannulation, but there is still uncertainty regarding their efficacy and safety compared to surgical removal (SR). Therefore, we conducted a meta-analysis to compare the application results of the two methods in VA-ECMO decannulation.</p><p><strong>Methods: </strong>Data from PubMed, Cochrane Library, and EMBASE databases were systematically searched through May 2024. Prospective or retrospective studies on the comparison of PPCDs and SR in VA-ECMO decannulation were included. The outcomes included technical success, bleeding events, infections at the decannulation site, vascular complications, overall complications, mortality and duration of hospitalisation.</p><p><strong>Results: </strong>Eight retrospective studies involving 618 patients were included. The results demonstrated that PPCDs significantly reduced infections at the decannulation site and overall complications [odds ratio (OR) = 0.14, 95% confidence interval (CI) 0.05-0.44, <i>P</i> < 0.001], (OR = 0.27, 95% CI 0.16-0.48, <i>P</i> < 0.001). No significant differences were observed in the incidence rates of bleeding events, vascular complications, mortality and duration of hospitalisation between the two groups (<i>P</i> > 0.05). Subgroup analysis revealed that the SR group had a significantly higher risk of the removal site infection compared to the percutaneous pre-closure group (OR = 0.06, 95% CI 0.01-0.29, <i>P</i> = 0.0003).</p><p><strong>Conclusion: </strong>Pre-closure techniques utilizing PPCDs demonstrate a significant advantage over SR in reducing the overall incidence of complications for VA-ECMO decannulation, particularly in terms of reducing infections at the decannulation site.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1482305"},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11906672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Instant termination as a novel indicator for prognosis of persistent atrial fibrillation during cryoballoon ablation: a propensity score-matched analysis.
IF 2.8 3区 医学
Frontiers in Cardiovascular Medicine Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.3389/fcvm.2025.1522086
Youqi Fan, Jian Ye, Xiaoya Wang, Liuguang Song, Yu Zhang, Yaping Wang
{"title":"Instant termination as a novel indicator for prognosis of persistent atrial fibrillation during cryoballoon ablation: a propensity score-matched analysis.","authors":"Youqi Fan, Jian Ye, Xiaoya Wang, Liuguang Song, Yu Zhang, Yaping Wang","doi":"10.3389/fcvm.2025.1522086","DOIUrl":"https://doi.org/10.3389/fcvm.2025.1522086","url":null,"abstract":"<p><strong>Background: </strong>Instant atrial fibrillation termination (AFT) during radiofrequency ablation has been suggested as a predictor of prognosis in persistent atrial fibrillation (AF). However, its role in cryoballoon ablation remains unclear. This study investigated the association between AFT and recurrent atrial tachyarrhythmia in patients with persistent AF undergoing cryoballoon ablation.</p><p><strong>Methods: </strong>Patients with non-valvular, drug-resistant, persistent AF who underwent cryoballoon ablation between January 2021 and June 2023 were included and categorized based on the presence or absence of AFT. Propensity score matching (PSM) was applied to eliminate covariate imbalances. Baseline characteristics, procedural details, and clinical outcomes were compared between the groups.</p><p><strong>Results: </strong>A total of 189 patients [65.0 (59.0-71.0) years] were included. Among them, 41 experienced instant AFT, while 148 remained in AF rhythm. The baseline conditions were similar, except that patients with AFT presented significantly lower left atrial diameter (LAD). During a follow-up of 16.0 [9.1-26.9] months, the recurrence rates of arrhythmias were significantly lower in the AFT group (log-rank <i>P</i> = 0.044). Both AFT [HR: 0.298, 95% CI: (0.091-0.976), <i>P</i> = 0.035] and baseline LAD [HR: 1.079, 95% CI: (1.012-1.151), <i>P</i> = 0.021] were independent predictors of recurrence. We further assessed the prognostic value of AFT in PSM groups which showed that the recurrence rates were also significantly lower in the AFT group (log-rank <i>P</i> = 0.049).</p><p><strong>Conclusion: </strong>Instant AFT during cryoballoon ablation is associated with a reduced risk of arrhythmic recurrence in patients with persistent AF.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1522086"},"PeriodicalIF":2.8,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11906448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信